Storys zum Thema Gesundheit

Folgen
Keine Story zum Thema Gesundheit mehr verpassen.
Filtern
  • 29.09.2025 – 19:31

    FAMAR Group

    FAMAR Group: Dr. Riku Rautsola Appointed New CEO

    Athens, Greece (ots/PRNewswire) - After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through ...

  • 21.08.2025 – 13:09

    Aktion Gesunder Rücken e. V.

    Health in the fast lane: How modern car seats protect our backs

    Bremervörde (Germany) (ots) - From autonomous driving to advanced safety technologies – the innovations presented at the IAA Mobility captivate car enthusiasts. However, one key comfort factor is often overlooked: the car seat. To meet the demand for ergonomic design, the production has become increasinglycomplex – up to 12 percent of a car’s development costs are attributable to the seat. “But not every seat ...

  • 24.07.2025 – 17:55

    Healthcare Holding Schweiz AG

    Mikrona Group Acquires FTC Dental

    Baar, Switzerland (ots/PRNewswire) - Mikrona Group AG, a leading Swiss provider of solutions for orthodontics and digital dentistry, has acquired FTC Frey Trading & Consulting Sàrl and its affiliated training platform, MYDENTALEXPERT Sàrl. Mikrona Group is part of Healthcare Holding Schweiz AG, which is managed by Winterberg Advisory and KKA Partners. Healthcare Holding Schweiz AG, through its subsidiary Mikrona Group AG, has completed the acquisition of FTC Frey Trading & ...

  • 17.06.2025 – 13:31

    Isomorphic Labs

    Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence

    London and Boston (ots/PRNewswire) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company's newly ...

  • 17.06.2025 – 09:02

    MedHub; Terumo

    MedHub-AI and Terumo partner to market AI-based FFR in Japan

    Tel Aviv, Israel (ots/PRNewswire) - MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market. This partnership marks a new era in coronary physiology assessment where AI technology delivers superior confidence, reproducibility, and clinical ...

  • 16.06.2025 – 13:40

    Innovative Molecules GmbH

    Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

    Munich (ots/PRNewswire) - Innovative Molecules GmbH Announces Completion of Phase 1b Enrollment for IM-250 in Genital Herpes Clinical Trial Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing Phase 1b/2a clinical trial evaluating IM-250, a next-generation helicase-primase inhibitor targeting herpes simplex virus ...

  • 04.06.2025 – 10:01

    Healthcare Holding Schweiz AG

    Healthcare Holding Switzerland Acquires Ino Medical Solutions

    Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Ino Medical Solutions GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH and KKA Partners. Healthcare Holding Schweiz AG has successfully completed the acquisition of Ino Medical Solutions GmbH, based ...

  • 02.06.2025 – 11:39

    BIAL SA

    BIAL Announces Oral Presentation at GBA1 Meeting 2025

    Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic ...

  • 02.06.2025 – 09:01

    Isotopia Molecular Imaging

    ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

    Petach Tikva, Israel (ots/PRNewswire) - ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential ...